CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 221 enrolled
Drug / intervention
ProVee Urethral Expander System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05186740
NCT05186740N/AActive
CompareCT.gov

The ProVee Urethral Expander System Clinical Study

ProVerum Medical·interventional·Posted Jan 11, 2022·Updated Apr 23, 2026

In Brief

A clinical study evaluating ProVee Urethral Expander System and Urethral Access Sheath for BPH With Symptomatic Lower Urinary Tract Symptoms. Active but no longer recruiting, targeting 221 participants across 17 sites in 3 countries.

Detailed Summary

A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBPH With Symptomatic Lower Urinary Tract Symptoms
CountriesCanada, Ireland, United States
Collaborators--

Timeline

N/AActive
20222023202420252026202720282029
First PostedJan 11, 2022
Enrollment StartJun 9, 2022
Primary CompletionMar 15, 2024
Study CompletionDec 1, 2028
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.5 years ago

Interventions

ProVee Urethral Expander Systemdevice

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Urethral Access Sheathprocedure

The Urethral Access Sheath is introduced into the prostatic urethra to simulate the placement of the ProVee Expander.